Prevention of spontaneous neu-expressing mammary tumor development in mice transgenic for rat proto-neu by DNA vaccination-Reference-Cited by-同舟云学术

Prevention of spontaneous neu-expressing mammary tumor development in mice transgenic for rat proto-neu by DNA vaccination

Published:2001-01 Issue:1 Volume:8 Page:75-79
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

Pupa SM,Invernizzi AM,Forti S,Carlo E Di,Musiani P,Nanni P,Lollini PL,Meazza R,Ferrini S,Ménard S

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/3301360.pdf

Reference33 articles.

1. Ménard S, Tagliabue E, Campiglio M, Pupa SM . Role of HER2 gene overexpression in breast carcinoma J Cell Physiol 2000 182: 150–162

2. Pupa SM, Ménard S, Andreola S, Colnaghi MI . Antibody response against the c-erbB-2 oncoprotein in breast carcinoma patients Cancer Res 1993 53: 5864–5866

3. Disis ML et al. High titer HER-2/neu protein specific antibody immunity can be detected in patients with early stage breast cancer J Clin Oncol 1997 15: 3363–3367

4. Fisk B, Blevins TL, Wharton JT, Ioannides CG . Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines J Exp Med 1995 181: 2109–2118

5. Peoples GE et al. Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide Proc Natl Acad Sci USA 1995 92: 432–436

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating autoantibodies to alpha-enolase (ENO1) and far upstream element-binding protein 1 (FUBP1) are negative prognostic factors for pancreatic cancer patient survival;Clinical and Experimental Medicine;2023-11-01

2. Single‐Cell Immunoblotting based on a Photoclick Hydrogel Enables High‐Throughput Screening and Accurate Profiling of Exogenous Gene Expression;Advanced Materials;2021-04-25

3. Cancer Immunoprevention: Current Status and Future Directions;Archivum Immunologiae et Therapiae Experimentalis;2021-02-27

4. Peptide-Based Cancer Vaccines and Therapeutics for Solid Tumors Overexpressing HER-1, HER-2, HER-3, VEGF and IGF-1R;Comprehensive Medicinal Chemistry III;2017

5. Chemo-immunotherapy induces tumor regression in a mouse model of spontaneous mammary carcinogenesis;Oncotarget;2016-07-28